Acasti Pharma (ACST) Reports Q2 Loss of $0.10

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. BIIB
7. CMG
8. TENB
9. KLAC
10. ETSY

Go back to Acasti Pharma (ACST) Reports Q2 Loss of $0.10

Acasti Pharma Reports First Quarter 2023 Operational Results

August 11, 2022 7:00 AM EDT

LAVAL, Québec, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Acasti or the Company) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases, today announced financial and operational results for the first quarter ended June 30, 2022.

Recent Highlights

The Company is preparing the GTX-104 PK bridging study results for submission to the U.S. Food and Drug Administration (FDA)... More